Regulatory News
Monday, November 28, 2016
BRIEF-Recro Pharma reports positive top-line results
* Recro pharma reports positive top-line results from
pivotal Phase III clinical trial of IV meloxicam
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment